Biolase Technology, Inc. (BLTI) Posts Second Consecutive Breakeven Quarter, Raises Q2 Revenue Guidance
Tweet Send to a FriendGet Alerts BLTI Hot Sheet
Price: $2.42 +2.54%
Revenue Growth %: +16.0%
Financial Fact:
Net loss: -2.63M
Today's EPS Names:
CO, JW-A, FDS, More
Revenue Growth %: +16.0%
Financial Fact:
Net loss: -2.63M
Today's EPS Names:
CO, JW-A, FDS, More
Trade BLTI Now!
Biolase Technology, Inc. (NASDAQ: BLTI) reported Q1 EPS of $0.00, $0.02 worse than the analyst estimate of $0.02. Revenue for the quarter came in at $10.6 million versus the consensus estimate of $9.56 million.
Biolase Technology, Inc. sees Q2 2011 revenue of $14-$15 million, versus the consensus of $16.82 million.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Biolase Technology, Inc. sees Q2 2011 revenue of $14-$15 million, versus the consensus of $16.82 million.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- La-Z-boy, Inc. (LZB) Tops Q4 EPS by 5c
- John Wiley (JW-A) Misses Q4 EPS by 9c; Names New CFO; Updates on Restructuring
- Five Below (FIVE) Tops Q1 EPS by 1c, Boosts FY13 Outlook
Create E-mail Alert Related Categories
Earnings, Hot Guidance
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
